Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed3

Role Distribution

Other Roles3

Activity Timeline

Clinical Trials (3)

NCT03110770Phase 2Completed
VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents
Flaviviral DiseasesFlaviviridae InfectionsFlavivirus Infections+4 more
StudychairStart date: 2017-03-29
NCT02562482Phase 2Completed
Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults
Chikungunya Virus Infection
StudychairStart date: 2015-11-18
NCT02354404Phase 1Completed
Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda
Hemorrhagic Fever, Ebola
StudychairStart date: 2015-01-27

Research Network

Collaboration Network

10 collaborators·30 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Bruno Hoen, MD

University Hospital Pointe-a-Pitre, Guadeloupe

Related
1 trials

Shared therapeutic areas:

Chikungunya Fever

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score14%

Nicolas Rosario, MD

San Juan Hospital

Related
1 trials

Shared therapeutic areas:

Chikungunya Fever

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score14%

Yeycy Donastorg, MD

Instituto Dermatológico y Cirugía de Piel

Related
1 trials

Shared therapeutic areas:

Chikungunya Fever

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score14%

Jean W Pape, MD

Centres GHESKIO, Haiti

Related
1 trials

Shared therapeutic areas:

Chikungunya Fever

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score14%

Grace Chen, MD

VRC, NIAID, NIH

Related
1 trials

Shared therapeutic areas:

Chikungunya Fever

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score14%

Andre Cabie, MD

Centre Hospitalier Universitaire (CHU), Martinique

Related
1 trials

Shared therapeutic areas:

Chikungunya Fever

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score14%

Clemente Diaz, MD

Puerto Rico Clinical and Translational Research Consortium

Related
1 trials

Shared therapeutic areas:

Chikungunya Fever

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)
Collaborated on 1 trial
Similarity Score14%

Merlin Robb, MD

US Military HIV Research Program

Related
3 trials

Shared therapeutic areas:

Hemorrhagic Fever, Ebola

Worked with same sponsors:

National Institute of Allergy and Infectious Diseases (NIAID)The Emmes Company, LLC+1 more
Collaborated on 1 trial
Similarity Score14%

Deborah Watson-Jones, PhD

London School of Hygiene and Tropical Medicine

Related
4 trials

Shared therapeutic areas:

Hemorrhagic Fever, EbolaRNA Virus InfectionsVirus Diseases
Similarity Score10%

Suchet R Patel, MD

Regional Clinical Research (RCR), Endwell (NY), USA

Related
2 trials

Shared therapeutic areas:

RNA Virus InfectionsVirus Diseases
Similarity Score7%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03110770Phase 2StudyChair

VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents

Flaviviral DiseasesFlaviviridae InfectionsFlavivirus Infections+4 more
Completed
NCT02562482Phase 2StudyChair

Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults

Chikungunya Virus Infection
Completed
NCT02354404Phase 1StudyChair

Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda

Hemorrhagic Fever, Ebola
Completed

All 3 trials loaded